Published in Eur J Nucl Med Mol Imaging on December 15, 2007
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis. J Am Coll Cardiol (2013) 3.86
¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging (2011) 1.15
Viral myocarditis-diagnosis, treatment options, and current controversies. Nat Rev Cardiol (2015) 1.09
Idiopathic giant cell myocarditis and cardiac sarcoidosis. Heart Fail Rev (2013) 1.05
Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment. Semin Respir Crit Care Med (2014) 1.04
ASCI 2010 appropriateness criteria for cardiac magnetic resonance imaging: a report of the Asian Society of Cardiovascular Imaging cardiac computed tomography and cardiac magnetic resonance imaging guideline working group. Int J Cardiovasc Imaging (2010) 0.98
Dilated cardiomyopathy with conduction disease and arrhythmia. Circulation (2010) 0.97
Sarcoidosis and the heart: A review of the literature. Intractable Rare Dis Res (2015) 0.95
Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med (2014) 0.91
Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med (2014) 0.87
18F-FDG PET/CT for the assessment of myocardial sarcoidosis. Curr Cardiol Rep (2013) 0.85
Elevated (18)F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis. Eur J Nucl Med Mol Imaging (2013) 0.84
Long fasting is effective in inhibiting physiological myocardial 18F-FDG uptake and for evaluating active lesions of cardiac sarcoidosis. EJNMMI Res (2014) 0.84
Management of cardiac sarcoidosis in the United States: a Delphi study. Chest (2011) 0.83
Infiltrative Cardiomyopathies. Clin Med Insights Cardiol (2015) 0.83
Comparison of (18)F-fluorodeoxyglucose positron emission tomography (FDG PET) and cardiac magnetic resonance (CMR) in corticosteroid-naive patients with conduction system disease due to cardiac sarcoidosis. Eur J Nucl Med Mol Imaging (2015) 0.79
Cardiac sarcoidosis: clinical manifestations, imaging characteristics, and therapeutic approach. Clin Med Insights Cardiol (2014) 0.78
Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther (2016) 0.76
Multimodality Imaging in Cardiac Sarcoidosis: Is There a Winner? Curr Cardiol Rev (2016) 0.75
Growing applications of FDG PET-CT imaging in non-oncologic conditions. J Biomed Res (2015) 0.75
Disease-specific cardiovascular positron emission tomography/magnetic resonance imaging: a brief review of the current literature. Quant Imaging Med Surg (2016) 0.75
Undiagnosed myocardial sarcoidosis presenting as life threatening cardiac dysrhythmia. BMJ Case Rep (2011) 0.75
Risk stratification for major adverse cardiac events and ventricular tachyarrhythmias by cardiac MRI in patients with cardiac sarcoidosis. Open Heart (2016) 0.75
Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: The potential role of occult inflammation in arrhythmogenesis. Heart Rhythm (2015) 0.75
Sarcoidosis: yet another masquerader the cardiologist / electrophysiologist has to fight with. Indian Pacing Electrophysiol J (2010) 0.75
Assessment of cardiac sarcoidosis with advanced imaging modalities. Biomed Res Int (2014) 0.75
Cardiovascular PET/MR: Potential Role and Challenges. Curr Cardiovasc Imaging Rep (2013) 0.75
Positron emission tomography imaging in sarcoidosis. World J Nucl Med (2013) 0.75
What type of different clinical manifestations can cardiac sarcoidosis present? Rheumatol Int (2014) 0.75
Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET/CT in cardiac sarcoid detection and therapy monitoring. J Nucl Cardiol (2017) 0.75
Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr (1990) 25.24
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation (1999) 11.04
Sarcoidosis. N Engl J Med (1997) 11.02
Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation (1978) 4.45
Sarcoidosis of the heart. A clinicopathologic study of 35 necropsy patients (group 1) and review of 78 previously described necropsy patients (group 11). Am J Med (1977) 4.34
Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med (1992) 3.31
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol (2005) 2.93
Usefulness of fasting 18F-FDG PET in identification of cardiac sarcoidosis. J Nucl Med (2004) 2.55
Clinicopathological study of fatal myocardial sarcoidosis. Ann N Y Acad Sci (1976) 2.47
Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J (2005) 2.30
Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET. J Nucl Med (2003) 2.03
Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation (2002) 1.97
Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med (2001) 1.85
Nonuniformity in myocardial accumulation of fluorine-18-fluorodeoxyglucose in normal fasted humans. J Nucl Med (1990) 1.77
Holter monitoring as a noninvasive indicator of cardiac involvement in sarcoidosis. Chest (1994) 1.69
Histologic diagnostic rate of cardiac sarcoidosis: evaluation of endomyocardial biopsies. Am Heart J (1999) 1.62
Myocardial late enhancement in contrast-enhanced cardiac MRI: distinction between infarction scar and non-infarction-related disease. AJR Am J Roentgenol (2005) 1.44
Myocardial sarcoidosis. Chest (1993) 1.39
Cardiac sarcoidosis: spectrum of MRI features. AJR Am J Roentgenol (2005) 1.37
Detection of myocardial involvement in patients with sarcoidosis applying T2-weighted, contrast-enhanced, and cine magnetic resonance imaging: initial results of a prospective study. J Comput Assist Tomogr (2002) 1.32
Cardiovascular magnetic resonance of acute myocardial infarction at a very early stage. J Am Coll Cardiol (2003) 1.17
Diagnostic and prognostic value of myocardial scintigraphy with thallium-201 and gallium-67 in cardiac sarcoidosis. Chest (1995) 1.16
Two-dimensional echocardiographic findings in systemic sarcoidosis. Am J Cardiol (1989) 1.15
The use of 2-[18F]fluoro-2-deoxy-D-glucose as a potential in vitro agent for labelling human granulocytes for clinical studies by positron emission tomography. Int J Rad Appl Instrum B (1992) 1.11
Lipoprotein lipase, hepatic lipase and plasma lipolytic activity. Effects of heparin and a low molecular weight heparin fragment (Fragmin). Acta Med Scand Suppl (1988) 1.00
Cardiac sarcoidosis. Diagnosis with endomyocardial biopsy and treatment with corticosteroids. Am J Cardiol (1978) 0.95
Images in cardiovascular medicine. Cardiac sarcoidosis evaluated by delayed-enhanced magnetic resonance imaging. Circulation (2003) 0.88
Steroid therapy in cardiac sarcoidosis. Increased left ventricular contractility concomitant with electrocardiographic improvement after prednisolone. Chest (1984) 0.88
Artifactual inhomogeneities in myocardial PET and SPECT scans in normal subjects. J Nucl Med (1995) 0.85
Cardiac sarcoidosis: reversion of myocardial perfusion abnormalities by dipyridamole. Eur J Nucl Med (1985) 0.82
Prognostic value of an increase in fluorine-18 deoxyglucose uptake in patients with myocardial infarction: comparison with stress thallium imaging. J Am Coll Cardiol (1993) 0.82
Positron emission tomography predicted recovery of complete A-V nodal dysfunction in a patient with cardiac sarcoidosis. Circulation (2002) 0.81
A unique presentation of cardiac sarcoidosis. AJR Am J Roentgenol (2003) 0.81
MR findings of myocardial sarcoidosis. Clin Radiol (2000) 0.80
Images in cardiovascular medicine. Multimodality imaging of cardiac sarcoidosis before and after steroid therapy. Circulation (2006) 0.80
ECG abnormalities in patients with sarcoidosis. Acta Med Scand (1983) 0.79
Images in cardiology. Cardiac sarcoidosis in a 60 year old woman. Heart (2006) 0.77
Detecting cardiac involvement in sarcoidosis: a call for prospective studies of newer imaging techniques. Eur Respir J (2007) 0.76
Combination of 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in assessing cardiac sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis (2005) 0.75
Changes in the peripheral vasculature of various organs in patients with sarcoidosis--possible role of microangiopathy. Heart Vessels (1986) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res (2004) 4.65
Airflow limitation and airway dimensions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 3.09
Overexpression of the aldo-keto reductase family protein AKR1B10 is highly correlated with smokers' non-small cell lung carcinomas. Clin Cancer Res (2005) 2.97
COPD in Japan: the Nippon COPD Epidemiology study. Respirology (2004) 2.81
Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J (2005) 2.30
Ganglioside GM3 participates in the pathological conditions of insulin resistance. J Biol Chem (2001) 2.04
The effect of nitroglycerin on myocardial blood flow in various segments characterized by rest-redistribution thallium SPECT. J Nucl Med (2003) 2.02
Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey. Ann Nucl Med (2011) 1.95
IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol (2006) 1.85
Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer. BMC Cancer (2007) 1.85
Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2008) 1.83
Biologic correlates of intratumoral heterogeneity in 18F-FDG distribution with regional expression of glucose transporters and hexokinase-II in experimental tumor. J Nucl Med (2005) 1.83
Virtual bronchoscopic navigation combined with endobronchial ultrasound to diagnose small peripheral pulmonary lesions: a randomised trial. Thorax (2011) 1.82
CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci (2003) 1.78
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer? J Nucl Med (2005) 1.73
Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J (2013) 1.69
Validation study on the accuracy of echocardiographic measurements of right ventricular systolic function in pulmonary hypertension. J Am Soc Echocardiogr (2012) 1.64
Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys (2003) 1.63
Bronchoscopic microsampling method for measuring drug concentration in epithelial lining fluid. Am J Respir Crit Care Med (2003) 1.62
Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol (2008) 1.62
Quantitative cerebral blood flow measurement with dynamic perfusion CT using the vascular-pixel elimination method: comparison with H2(15)O positron emission tomography. AJNR Am J Neuroradiol (2003) 1.61
Characterisation of phenotypes based on severity of emphysema in chronic obstructive pulmonary disease. Thorax (2007) 1.61
Detection of apoptotic tumor response in vivo after a single dose of chemotherapy with 99mTc-annexin V. J Nucl Med (2003) 1.60
Diagnostic accuracy of lymph node metastasis depends on metabolic activity of the primary lesion in thoracic squamous esophageal cancer. J Nucl Med (2013) 1.60
Clinical characteristics of pleomorphic carcinoma of the lung. Lung Cancer (2009) 1.55
Steep dose-response relationship for stage I non-small-cell lung cancer using hypofractionated high-dose irradiation by real-time tumor-tracking radiotherapy. Int J Radiat Oncol Biol Phys (2007) 1.49
Lower leptin/adiponectin ratio and risk of rapid lung function decline in chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 1.49
Association between body mass index and asthma among Japanese adults: risk within the normal weight range. Int Arch Allergy Immunol (2011) 1.48
Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease. World Neurosurg (2012) 1.48
The effect of scatter correction on 123I-IMP brain perfusion SPET with the triple energy window method in normal subjects using SPM analysis. Eur J Nucl Med Mol Imaging (2002) 1.45
Contrasting associations of body mass index and measles with asthma and rhinitis in young adults. Allergy Asthma Proc (2015) 1.45
Dominant-negative hypoxia-inducible factor-1 alpha reduces tumorigenicity of pancreatic cancer cells through the suppression of glucose metabolism. Am J Pathol (2003) 1.45
Diagnostic value of endobronchial ultrasonography with a guide sheath for peripheral pulmonary lesions without X-ray fluoroscopy. Chest (2007) 1.43
Effects of surgical ventricular reconstruction and mitral complex reconstruction on cardiac oxidative metabolism and efficiency in nonischemic and ischemic dilated cardiomyopathy. JACC Cardiovasc Imaging (2011) 1.42
Factors related to diagnostic yield of transbronchial biopsy using endobronchial ultrasonography with a guide sheath in small peripheral pulmonary lesions. Chest (2007) 1.42
Intravascular ultrasound assessment of postprocedural incomplete stent apposition. J Invasive Cardiol (2012) 1.42
Validation of automated quantitation of myocardial perfusion and fatty acid metabolism abnormalities on SPECT images. Circ J (2011) 1.42
Proteinuria and Reduced Estimated Glomerular Filtration Rate Are Independent Risk Factors for Contrast-Induced Nephropathy After Cardiac Catheterization. Circ J (2015) 1.42
Small cell carcinoma of the lung exclusively localized within the left descending pulmonary artery. Chest (2005) 1.42
Prediction of functional recovery after revascularization using quantitative gated myocardial perfusion SPECT: a multi-center cohort study in Japan. Eur J Nucl Med Mol Imaging (2008) 1.40
Interpretative variability and its impact on the prognostic value of myocardial fatty acid imaging in asymptomatic hemodialysis patients in a multicenter trial in Japan. Circ J (2014) 1.39
Reduced 123I-BMIPP uptake implies decreased myocardial flow reserve in patients with chronic stable angina. Eur J Nucl Med Mol Imaging (2005) 1.39
Cardiac functional analysis with multi-detector row CT and segmental reconstruction algorithm: comparison with echocardiography, SPECT, and MR imaging. Radiology (2005) 1.39
Prognostic value of circulating KL-6 in idiopathic pulmonary fibrosis. Respirology (2006) 1.37
Lung adenocarcinoma presenting with enlarged and multiloculated cystic lesions over 2 years. Respir Care (2004) 1.31
Role of macrophage migration inhibitory factor in bleomycin-induced lung injury and fibrosis in mice. Am J Physiol Lung Cell Mol Physiol (2002) 1.29
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection. Cancer Immunol Immunother (2010) 1.25
Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas. Int J Radiat Oncol Biol Phys (2002) 1.23
Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer. Eur J Nucl Med Mol Imaging (2013) 1.21
Lung tumors evaluated with FDG-PET and dynamic CT: the relationship between vascular density and glucose metabolism. J Comput Assist Tomogr (2002) 1.19
Quantitative analysis of coronary endothelial function with generator-produced 82Rb PET: comparison with 15O-labelled water PET. Eur J Nucl Med Mol Imaging (2010) 1.17
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. Respiration (2003) 1.17
HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer. Cancer Sci (2007) 1.16
Performance characterization of the Inveon preclinical small-animal PET/SPECT/CT system for multimodality imaging. Eur J Nucl Med Mol Imaging (2010) 1.15
Assessment of cervical lymph node metastases using FDG-PET in patients with head and neck cancer. Ann Nucl Med (2008) 1.15
¹⁸F-Fluoro-2-deoxyglucose positron emission tomography in cardiac sarcoidosis. Eur J Nucl Med Mol Imaging (2011) 1.15
A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. Am J Respir Crit Care Med (2002) 1.15
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells. Lung Cancer (2012) 1.15
Non-responsiveness to gefitinib in a patient with lung adenocarcinoma having rare EGFR mutations S768I and V769L. Lung Cancer (2006) 1.13
Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions. J Nucl Med (2013) 1.11
High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer. J Nucl Med (2013) 1.11
A new PET scanner with semiconductor detectors enables better identification of intratumoral inhomogeneity. J Nucl Med (2008) 1.11
Reduction of coronary flow reserve in areas with and without ischemia on stress perfusion imaging in patients with coronary artery disease: a study using oxygen 15-labeled water PET. J Nucl Cardiol (2003) 1.09
FDG-PET for the diagnosis of fever of unknown origin: a Japanese multi-center study. Ann Nucl Med (2011) 1.09
Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer. Eur J Nucl Med Mol Imaging (2002) 1.08
CT-guided transbronchial biopsy using an ultrathin bronchoscope with virtual bronchoscopic navigation. Chest (2004) 1.08
Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy. Int J Radiat Oncol Biol Phys (2005) 1.08
What we have learned from Fukushima. Eur J Nucl Med Mol Imaging (2011) 1.07
The effect of tumor location and respiratory function on tumor movement estimated by real-time tracking radiotherapy (RTRT) system. Int J Radiat Oncol Biol Phys (2005) 1.07
Human brain region response to distention or cold stimulation of the bladder: a positron emission tomography study. J Urol (2002) 1.07
Recurrent gefitinib-induced interstitial lung disease. Intern Med (2008) 1.06
Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging (2002) 1.06
Transbronchial biopsy using endobronchial ultrasonography with a guide sheath and virtual bronchoscopic navigation. Chest (2005) 1.06
Functional polymorphisms in the promoter region of macrophage migration inhibitory factor and atopy. Am J Respir Crit Care Med (2004) 1.06
Decreased airway expression of vascular endothelial growth factor in cigarette smoke-induced emphysema in mice and COPD patients. Inhal Toxicol (2008) 1.06
Chemokines in bronchiolar epithelium in the development of chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol (2004) 1.05